Intelligence Platform
Patents
Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7919301
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of reco
granted patentUS 7914788
Monoclonal antibodies against orthopoxviruses
granted patentUS 7910587
Quinoxalinyl dipeptide hepatitis C virus inhibitors
granted patentUS 7906292
Localization and characterization of flavivirus envelope glycoprotein cross-reactive epito
granted patentUS 7901921
Viral purification methods
granted patentUS 7897152
Viral chemokine-antigen fusion proteins
granted patentUS 7888069
Plant-made west nile virus (WNV) vaccines, vectors and plant codon optimized sequences
granted patentUS 7875450
Virus-like particles for the induction of autoantibodies
granted patentUS 7871814
Recombinant bicistronic flaviviruses and methods of use thereof
granted patentUS 7868162
Antimicrobial and antiviral compounds and methods for their use
granted patentUS 7867476
Method and materials for use in diagnosing viral myocarditis
granted patentUS 7863041
Rabies virus vector systems and compositions and methods thereof
granted patentUS 7862821
Recombinant vaccine against bluetongue virus
granted patentUS 7851194
West Nile viruses with mutations in the 3β² terminal stem and loop secondary structure for
granted patentUS 7846454
Cloned genomes of infectious hepatitis C viruses and uses thereof
granted patentUS 7846455
Attenuated chimeric respiratory syncytial virus
granted patentUS 7842798
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
granted patentUS 7833533
Enhanced antiviral activity against foot and mouth disease
granted patentUS 7829102
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
granted patentUS 7824690
Marek's disease virus vaccine
granted patentUS 7820631
Anti-viral pyrimidine nucleoside analogues
granted patentUS 7820182
Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in i
granted patentUS 7820181
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of reco
granted patentUS 7807179
Modified reoviral therapy
granted